EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients

Hadiza Rabe Musa, Amina Rabe Musa, Yahuza Gimba Muhammed, Usman Salisu Batagarawa, Aminu Ibrahim

BioMed Target Journal · 2024

DOI: 10.59786/bmtj.223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Target Journal, 2024. Verfasst von Hadiza Rabe Musa und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy, a serious complication of diabetes, may be influenced by genetic factors, including the Aldose Reductase (ALR2) gene polymorphism. There is a crucial need to understand how the polymorphism in the ALR2 gene contributes to diabetic retinopathy. This study aimed to explore and evaluate the impact of ALR2 gene polymorphism on diabetic retinopathy, alongside assessing inflammatory markers and antioxidant status among diabetic patients residing in Kano State, Nigeria. In this study, 40 participants were enrolled; the participants were divided into 4 groups, with three test groups (diabetes mellitus, cataract, and diabetic retinopathy groups) and the control group. The investigation encompassed and incorporated the prevalence of the SNP C(-106)T polymorphism within the ALR2 promoter region, in combination with the assessment of inflammatory markers (C-reactive protein [CRP] and high-sensitivity C-reactive protein [hsCRP]), malondialdehyde (MDA) levels, vitamin A and aldose reductase concentrations. The findings revealed a 6.7% prevalence of the SNP C(-106)T polymorphism. Fasting blood glucose and HbA1c levels were significantly (p 0.05) observed correlation between ALR2 and MDA (r= 0.026) or CRP (r= -0.077). The study identified a 6.7% prevalence of ALR2 gene polymorphism in diabetic retinopathy patients, alongside elevated inflammatory markers and MDA levels. Moreover, in the present finding, all control group had the C (CC genotype) allele, while the study group had 90% C allele and 10% T allele. The T allele showed no significant association with DR 1.00 (OR 95% CI: 0.127-7.893; p:1.00). However, Additional research with larger sample sizes is warranted to comprehensively investigate the implications of the SNP C(-106)T polymorphism at the ALR2 promoter region.

Zitieren

APA

Musa, H. R., Musa, A. R., Muhammed, Y. G., Batagarawa, U. S., & Ibrahim, A. (2024). Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients. BioMed Target Journal. https://doi.org/10.59786/bmtj.223

Vancouver

Musa HR, Musa AR, Muhammed YG, Batagarawa US, Ibrahim A. Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients. BioMed Target Journal. 2024. doi:10.59786/bmtj.223

BibTeX
@article{Musa2024,
  author = {Musa, Hadiza Rabe and Musa, Amina Rabe and Muhammed, Yahuza Gimba and Batagarawa, Usman Salisu and Ibrahim, Aminu},
  title = {Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients},
  journal = {BioMed Target Journal},
  year = {2024},
  doi = {10.59786/bmtj.223}
}
Kostenlos starten →